Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa
Status:
Completed
Trial end date:
2015-08-11
Target enrollment:
Participant gender:
Summary
The purpose of the study is to demonstrate the clinical therapeutic non-inferiority of EXL
CDOS to commercially available Ciprofloxacin 0.3% and Dexamethasone 0.1% Sterile Otic
Suspension (Ciprodex®, Alcon) in the treatment of acute otitis externa (AOE) when
administered twice daily for 7 days.